Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document provides an overview of Atreca's immunotherapy potential, detailing their research, development programs, and future plans in oncology.
investor_presentation
investor_presentation
22 Pages
Ironwood Pharmaceuticals
Mettler-Toledo International Investor Presentation — May 2024
investor_presentationinvestor_presentation
7 Pages
Mettler-Toledo International Inc.